Quantbot Technologies’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Quantbot Technologies’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-84	Closed	-$8K	–	1376
2016 Q2	$8K	Buy	+84	New	+$10.4K	﹤0.01%	980
2015 Q4	–	Sell	-278	Closed	-$89K	–	1435
2015 Q3	$89K	Buy	278 +145	+109%	+$63.7K	0.02%	792
2015 Q2	$53K	Buy	+133	New	+$56.5K	0.01%	806
2014 Q4	–	Sell	-459	Closed	-$88K	–	1451
2014 Q3	$88K	Buy	+459	New	+$101K	0.01%	887
2014 Q2	–	Sell	-144	Closed	-$36K	–	1427
2014 Q1	$36K	Buy	+144	New	+$44K	0.01%	866

Other funds holding LUMO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Quantbot Technologies's LUMO Position: Q3 2016 in Review

Quantbot Technologies sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2016, closing a stake of 84 shares — an estimated $8K sold.

Quantbot Technologies first reported a position in LUMO in Q1 2014 and held it in 5 quarters. The position peaked at $89K in Q3 2015. 105 funds tracked by Wall St. Rank hold LUMO as of Q3 2016.

Quantbot Technologies reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Quantbot Technologies sold 84 Lumos Pharma, Inc. Common Stock shares in Q3 2016, an estimated $8K.
Quantbot Technologies first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 5 quarters.
Quantbot Technologies's Lumos Pharma, Inc. Common Stock position peaked at $89K in Q3 2015.
105 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2016.

Based on Quantbot Technologies's 13F filing for Q3 2016, filed 31 Oct 2016.